Advertisement

European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013

Michele Baccarani, Michael W. Deininger, Gianantonio Rosti, Andreas Hochhaus, Simona Soverini, Jane F. Apperley, Francisco Cervantes, Richard E. Clark, Jorge E. Cortes, François Guilhot, Henrik Hjorth-Hansen, Timothy P. Hughes, Hagop M. Kantarjian, Dong-Wook Kim, Richard A. Larson, Jeffrey H. Lipton, François-Xavier Mahon, Giovanni Martinelli, Jiri Mayer, Martin C. Müller, Dietger Niederwieser, Fabrizio Pane, Jerald P. Radich, Philippe Rousselot, Giuseppe Saglio, Susanne Saußele, Charles Schiffer, Richard Silver, Bengt Simonsson, Juan-Luis Steegmann, John M. Goldman and Rüdiger Hehlmann

Article Information

Citation 
vol. 122 no. 6 872-884
PubMed 

Print ISSN 
Online ISSN 
History 
  • Submitted May 8, 2013
  • Accepted June 10, 2013
  • Published online August 8, 2013.

Article Versions


Contributors 
  • Michele Baccarani, 1Department of Hematology “L. and A. Seràgnoli,” S.Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy;
  • Michael W. Deininger, 2Division of Hematology and Hematologic Malignancies, University of Utah Huntsman Cancer Institute, Salt Lake City, UT;
  • Gianantonio Rosti, 3Department of Experimental, Diagnostic, and Specialty Medicine, University of Bologna and S.Orsola-Malpighi Hospital, Bologna, Italy;
  • Andreas Hochhaus, 4Hematology/Oncology, Universitätsklinikum Jena, Jena, Germany;
  • Simona Soverini, 3Department of Experimental, Diagnostic, and Specialty Medicine, University of Bologna and S.Orsola-Malpighi Hospital, Bologna, Italy;
  • Jane F. Apperley, 5Centre for Hematology, Imperial College, London, United Kingdom;
  • Francisco Cervantes, 6Hospital Clinic, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Barcelona, Spain;
  • Richard E. Clark, 7Royal Liverpool University Hospital, Liverpool, United Kingdom;
  • Jorge E. Cortes, 8Department of Leukemia, MD Anderson Cancer Center, Houston, TX;
  • François Guilhot, 9Institut National de la Santé et de la Recherche Médicale Centres d'investigation clinique 0802, CHU de Poitiers, Université de Poitiers, Poitiers, France;
  • Henrik Hjorth-Hansen, 10Department of Hematology, St. Olavs Hospital, and Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway;
  • Timothy P. Hughes, 11SA Pathology and University of Adelaide, Adelaide, SA, Australia;
  • Hagop M. Kantarjian, 8Department of Leukemia, MD Anderson Cancer Center, Houston, TX;
  • Dong-Wook Kim, 12Department of Hematology, Seoul St. Mary’s Hospital, The Catholic University of Korea, Seoul, South Korea;
  • Richard A. Larson, 13The University of Chicago, Chicago, IL;
  • Jeffrey H. Lipton, 14Princess Margaret Hospital, University of Toronto, ON, Canada,
  • François-Xavier Mahon, 15Laboratoire d’ Hématologie CHU de Bordeaux et Laboratoire Hématopoïese Leucémique et Cible Therapeutique, Université Bordeaux Ségalen, Institut National de la Santé et de la Recherche Médicale 1035, Bordeaux, France;
  • Giovanni Martinelli, 3Department of Experimental, Diagnostic, and Specialty Medicine, University of Bologna and S.Orsola-Malpighi Hospital, Bologna, Italy;
  • Jiri Mayer, 16University Hospital Brno and Central European Institute of Technology Masaryk University, Brno, Czech Republic;
  • Martin C. Müller, 17III Medizinische Klinik, Universitätsmedizin Mannheim, Mannheim, Germany;
  • Dietger Niederwieser, 18Department of Hematology and Oncology, University of Leipzig, Leipzig, Germany;
  • Fabrizio Pane, 19Dipartimento di Medicina Clinica e Chirurgia, Università di Napoli Federico II, and CEINGE Biotecnologie Avanzate, Napoli, Italy;
  • Jerald P. Radich, 20Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA;
  • Philippe Rousselot, 21Service d’ Hématologie et d’ Oncologie, Hôpital Mignot, Université Versailles Saint-Qentin-en-Yvelines, Versailles, France;
  • Giuseppe Saglio, 22Department of Oncology, University of Turin, Turin, Italy;
  • Susanne Saußele, 17III Medizinische Klinik, Universitätsmedizin Mannheim, Mannheim, Germany;
  • Charles Schiffer, 23Division of Medicine and Oncology, Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI;
  • Richard Silver, 24Weill Cornell Medical College, New York, NY;
  • Bengt Simonsson, 25University Hospital, Uppsala, Sweden;
  • Juan-Luis Steegmann, 26Servicio de Hematologia, Hospital Universitario de la Princesa, IIS-IP, Madrid, Spain; and
  • John M. Goldman, 27Department of Hematology, Imperial College, London, United Kingdom
  • Rüdiger Hehlmann, 17III Medizinische Klinik, Universitätsmedizin Mannheim, Mannheim, Germany;

Altmetric.com Statistics

The Altmetric score is a weighted count of online attention designed to reflect the volume and reach of online engagement surrounding an individual research output